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ABSTRACT
Background: a review of the literature found no clinical studies in which low level laser therapy (LLLT) 
and high voltage pulsed current (HVPC) were compared to evaluate their effectiveness in promoting 
wound healing. Objective: The purpose of this study was compare the effects of LLLT, HVPC and 
standard wound care (SWC) on the healing of diabetic foot ulcers. Methods: randomized controlled 
clinical trial where diabetic patients were divided in control group (CG) treated with SWC; HVPC group 
received HVPC plus SWC; LLLTgroup, treated with LLLT plus SWC. HVPC was applied 45min, 100pps 
and 100µs. LLLTparameters were 685nm, 30mW,2J/cm2 applied to the wound edges and 1,5J/cm2 in the 
wound bed. All subjects were treated 16 weeks or until the wound closed. The variables were healing, 
healing proportion, ulcers’s characteristics, protective sensation, nerve conduction studies (NCS) and 
quality life. ANCOVA analysis and a Fisher´s exact test were applied. Results: Twenty-eight subjects 
completed the protocol.The healing was reached by 7/9, 8/10 and 6/9 participants of the LLLT, HVPC 
and CG respectively in the 16th week. There were no statistically significant differences between the 
groups in the healing proportion, NCS, sensory testing or quality of life (p>0,05). Conclusions: The 
results of this study did not demonstrated additional effects of LLL or HVPC to the standard wound care 
(SWC) on healing of diabetic ulcers.
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RESUMEN
Introducción: La literatura revisada no registró estudios que compararan la efectividad del láser debaja potencia 
(LBP) y la corriente pulsada de alto voltaje (CPAV) sobre la cicatrización de úlceras diabéticas. Objetivo: Comparar 
los efectos del LBP, la CPAV y el cuidado de enfermería estándar (CEE) sobre la cicatrización de úlceras diabéticas.
Métodos: Ensayo clínico controlado con asignación a: grupo control (GC) tratado con CEE; (CPAV) recibió CPAV 
más CEE y (LBP) tratado con LBP más CEE. La CPAV se aplicó por 45min, 100pps y 100µs. Los parámetros del 
LBP fueron 685NM, 30mW y 2J/cm2 aplicado en los bordes de la herida y 1,5J/cm2 en los bordes de la herida. 
Todas las personas fueron tratadas por 16 semanas o hasta el cierre de la herida. Las variables fueron cicatrización, 
proporción de cicatrización, características de las úlceras, sensación protectora, estudios de conducción nerviosa 
(ECN) y calidad de vida. Para el análisis se aplicaron un ANCOVA y el test exacto de Fisher. Resultados: El 
protocolo fue completado por 28 personas. La cicatrización se logró en 7/9, 8/10 y 6/9 participantes de LBP, CPAV 
y CEE respectivamente, hasta la semana 16. No hubo diferencias significativas entre los grupos en la proporción de 
cicatrización, ECN, evaluación sensorial o calidad de vida (p>0,05). Conclusión: Los resultados de este estudio no 
demostraron efectos adicionales del LBP o de la CPAV, al cuidado de enfermería estándar, sobre la cicatrización de 
úlceras de pie diabético. 
Palabras clave: estimulación eléctrica, terapia láser, úlceras de pie, diabetes.
INTRODUCTION
Diabetes mellitus (DM) is a disease in which the body 
does not produce or properly use insulin. This disease 
has increased by 100 % over the past two decades 
in countries like the USA and it is expected to have 
increased by an additional 165 % by 2050 1.
DM causes chronic complications like diabetic foot 
ulcers produced by multiple etiologies, including 
neuropathy and peripheric vascular disease. Diabetic 
foot ulcers often lead to deformity, infection and 
trauma 2.  The treatment costs are high, especially due 
to prolonged hospitalization, rehabilitation and social 
relocation of the individual.
Lower extremity amputation is one of the consequences 
of diabetic foot ulceration; it significantly affects 
patient’s quality of life and increases mortality by 39 
% to 68 % 3. The  annual incidence of lower extremity 
amputation varies from 5,3 to 8,1 per 1000 people with 
DM. The risk of lower-limb amputation is 30 to 40 times 
higher in the diabetic than the nondiabetic population 4.
The complexity of these ulcers requires an 
interdisciplinary approach, focusing on prevention, 
education  and  treatment of  patients with diabetic 
foot ulcers; this strategy can lead to  amputation being 
reduced by  50 % 2.
Diabetic foot ulcers can be treated by using either 
high voltage pulsed current (HVPC) or  low level 
laser therapy (LLLT). High rates of healing have been 
reported following the treatment of several types of 
wound 5-17, mainly with the HVPC. This modality 
increases local blood flow, measured by transcutaneous 
oxygen pressureTcPO2, there by accelerating the 
healing process and promoting a bactericidal effect 8-15. 
Gardner 15 in one meta-analysis quantified the effect 
of electrical stimulation on healing diverse types of 
wound, concluding that such intervention produced a 
22 % healing rate compared to 9 % for control  wounds.
The results of using laser for treating humans are 
contradictory because just a few well-conducted clinical 
trials have been published. There are some studies 
confirming the efficacy of laser in healing wounds in 
humans 7,16, but others have not shown statistically 
significant differences between groups 17,18.
Among the possible LLLT mechanisms that accelerate 
the healing process are increase in ATP production, 
DNA, RNA total content, collagen synthesis and 
fibroblast proliferation 5. There is also evidence that 
LLLT increases local blood flow, thereby increasing 
oxygen saturation and epithelization 6.  It  has also been 
suggested that laser might improve sensory perception 
in patients suffering peripheral neuropathy; however 
the results are not conclusive 19,20.
While the available evidence supports the effectiveness 
of the LLLT and HVPC in enhancing wound healing, 
no clinical trials comparing the effectiveness of the 
two biophysical agents were found. The purpose of this 
study was to compare the additional effects of LLLT 
or HVPC to the standard wound care (SWC) alone on 
healing of diabetic foot ulcers.
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MATERIALS AND METHODS
Participants
Volunteers who fulfilled the following criteria were 
included in the present study: 30 to 75 years old with 
confirmed diagnosis of DM (diagnosis based on WHO 
criteria), with ulcers localized on the distal legs or feet, 
classified as category I or II according to the Wagner 
Classification System. Subjects with uncontrolled 
diabetes, local infection in the ulcer site, ulcer grades 
III through V (Wagner classification), lower limb 
amputation and neuromuscular or musculoskeletal 
disease were excluded from the study. The diagnosis 
of DM was verified by glycemia values prior to the 
intervention. Each participant was examined clinically 
by an endocrinologist to confirm the inclusion criteria 
and subsequent evaluation of DM during the study.
This study was approved by the Ethics Committee of 
the Universidad Industrial de Santander, and all subjects 
signed an informed consent form. Also was registered 
as NCT00719251 - clinical trials.gov
Study Design  
A randomized controlled clinical trial  was performed. 
Subjects were randomly assigned to one of three groups: 
control group (CG) treated with standard wound care 
(SWC); high voltage pulsed current group (HVPC) who 
received  HVPC plus SWC; the low level laser therapy 
group (LLLT), who were treated with LLLT plus SWC. 
The randomization process was performed according to 
a pre-established order, using randomized blocks.
Two physical therapists (each having 20 years of 
experience) conducted all the measurements; evaluators 
were blinded regarding group assignment. SWC was 
performed by a trained nurse; finally  the HVPC and 
LLLT treatments were performed by one physical 
therapist. 
Outcomes
Primary outcome: 
Healing: defined as yes or no, if  a  closure of at least 75 
% or more of the sum of areas of all ulcers per patient 
ocurred after the 16th week of intervention.
Secondary outcomes:
Healing Proportion :measurement obtained as the 
percent of baseline area, based on the sum of the areas of 
all ulcers per patient, for weeks 4, 8, 12 and 16 defined 
as follows: [(initial area – end area)/ initial area x 100].
Characteristics of the ulcers: Wounds were 
categorized using the Wagner Classification System. 
This system assess the wound depth, infection and 
ischemia and gives six wound stages. The ulcer location 
was identified on a picture of the foot and distal leg with 
views of the lateral and plantar foot.  The wound surface 
area was measured using the acetate tracing method; 
this involved directly applying a clean transparent 
film to the wound and then tracing the wound edges. 
This tracing was transposed onto graph-paper and then 
scanned to determine wound area in cm2 using Image 
1,39 usoftware (National Institutes of Health, USA). 
Wound depth was measured by using a sterile cotton-
tipped applicator which was placed into the deepest 
part of the wound and then withdrawn and measured 
in millimeters. Ulcer progression toward healing was 
determined by surface area measurement recorded in 
months.
Protective Sensation Test and Nerve Conduction 
Studies (NCS): Peripheral nerve function was assessed 
by using the protective sensation testing and NCS of 
the sural, medial plantar and posterior tibial nerves. 
Data from these tests were used to show whether the 
therapeutic interventions induce changes in a patient’s 
neuropathic status.
Protective sensation was examined using the Semmes-
Weinstein monofilament test (Touch-TestTM) which 
is considered a sensitive method for determining the 
presence or absence of protective sensation in the 
neuropathic diabetic foot. The monofilament test was 
selected and modified from Sangyeop method where a 
10 g monofilament was applied only once to each of 
10 points on the foot’s plantar surface. However, some 
of the 10 points were not located within the medial 
plantar nerve and sural nerve’s cutaneous distribution 
area. Sangyeop’s test was thus modified by increasing 
the number of test points to 20, 10 points being located 
within the medial plantar nerve’s distribution area 
and 10 within the sural nerve’s distribution area. An 
abnormal protective sensation was defined as being 
the inability to perceive the monofilament at 6 or more 
evaluation sites for each nerve.
All NCS of the affected lower extremity were recorded 
using a Nicolet Compass MeridianTM   (Madison, WI, 
USA). Sensory studies of the medial plantar and sural 
nerves were performed  with a 20Hz to 3kHz band width 
setting, a 20 µV/division gain for the sural and 2 µV/
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division for medial plantar and a 1 ms/division sweep 
speed.  The nerve signals were obtained by averaging 
20 responses evoked with 100µs rectangular pulses 
having amplitude adjusted to slightly more than that 
required to ensure a maximum response. The medial 
plantar nerve was studied by the orthodromic method. 
The nerve was stimulated through two ring electrodes 
placed around the hallux which was separated from the 
second toe by a strip of plastic sheeting. The  recording 
electrode was placed over a point at which the posterior 
tibial artery could be palpated, close to the medial 
malleolus of the ankle.  Antidromic NCS for the sural 
nerve was performed by placing the recording electrode 
just behind the lateral malleolus. The stimulating 
electrode was about 14cm proximal to the active 
recording electrode, immediately lateral to the midline 
of the calf muscle.  The ground electrode was placed on 
the calf muscle.
Motor studies were obtained with a bandwidth setting 
of 2Hz to 10kHz, sensitivity of 2mV/div, and sweep 
speed of 2ms/div.These settings were modified in case 
of abnormal NCS. Motor fibers of the posterior tibial 
nerve were tested by employing the belly-tendon 
method. The  recording electrode was placed over the 
abductor hallucis muscle and the reference electrode 
at the base of the hallux. The ground electrode was 
positioned on the calf muscle. The distal stimulation site 
was at the ankle, just behind the medial malleolus. The 
proximal stimulation site was at the knee, just medial to 
the midpoint of the knee crease.
Abnormal NCS was established as follows: <34,68m/s 
for the sural nerve, <40,63m/s for the posterior tibial and 
<24,4m/s for the plantar nerve. When compound action 
potential was not detected, the NCS was classified as 
being absent.
Quality of life
Euroquol - 5D (EQ-5D) self-report questionnaire was 
used; this is a generic measurement of health-related 
quality of life that generates a single index value 
based on five dimensions (mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression). 
Each dimension has three response categories identified 
as: no problem, some problem and extreme problem. 
A participant can also assess his/her own overall daily 
health status on the EQ-5D on a 0-100 scale (EQ VAS).
Explanatory variables
Evaluation time: Wound characteristics were evaluated 
at the beginning of the study, prior to debridement, every 
two weeks during the intervention, at the end of the 
treatment (16th week), 30 and 60 days after the protocol 
had been completed. Monofilament testing, NCS and 
quality of life were performed at the beginning and end 
of the treatment.
Interventions
Standard Wound Care (SWC): This treatment 
was performed according to nursing intervention 
classification (NIC) recommendations. The procedure 
included irrigation with physiological saline solution, 
selective sharp debridement of necrotic tissue and 
maintaining a moist environment by applying an 
appropriate wound dressing. The patients were also 
taught diabetic foot self-care and  pressure off-loading 
in the affected foot. All patients received SWC seven 
days a week for 16 weeks or until wound closure 
ocurred. Three days per week  the patients attended 
the laboratory for SWC and their respective treatment 
(HVPC or LLLT), while on the other four days the 
nurse visited subjects at home to apply SWC.
High Voltage Pulsed Current (HVPC): wounds were 
treated with HVPC for 45 min three times a week for 
16 weeks or until the wound closed. The treatment 
electrode was made of heavy-duty aluminum foil 
which was directly secured on steril saline-moist gauze 
loosely packed into the wound. The non-treatment 
(dispersive) electrode was applied 5cm from the wound 
edge on the same skin surface. The electrical stimulator 
used (Intelect 340 Stim model- Chattanooga Group) 
produced a twin peak pulse having the following 
parameters: continuous mode, submotor voltage 
level, 100 pulses per second (pps)  pulse frequency 
and  100µs pulse duration. Active electrode polarity 
was negative (cathod) during the first three treatment 
sesions and then changed to positive (anode) until the 
end of the treatment 21. Prior to beginning the study,  the 
electrical stimulator was calibrated with an oscilloscope 
(Tektronix Inc.- USA).
Low level laser theray (LLLT):semiconductor laser 
diode (DMC - Brazil) with 685 nm wavelength emitted 
30 mW in continuous mode, 0,0028cm2 beam area 
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applied punctually at 2J/cm2 (0,18s) every centimeter 
along the edges of the ulcer in light contact and 1,5J/
cm2 (0,14s) in the wound bed in non-contact mode, 
three times a week for 16 weeks or until the wound 
closed. Regarding energy density, a 3 to 5 J/cm2 dose 
has provided better wound healing results 16,22,23. One 
study concluded that high doses of photoenergy are 
very aggressive and may therefore decrease cellular 
proliferation and healing rate 5, thereby corroborating 
the dose-dependency effect of laser light, previously 
demonstrated in in- vitro studies 23.  The laser probe was 
cleaned with a disinfectant prior to use; the laser was 
also calibrated with a research radiometer (International 
Light Technologies) prior to the study. 
Data Analysis 
The results followed the Consolidated Standards of 
Reporting Trials (CONSORT) recommendations for 
RCTs. The subjects were compared at the baseline 
on demographic and clinical characteristics, wound 
characteristics, protective sensation and NCS for sural, 
medial plantar and posterior tibial nerves, by an analysis 
of variance (ANOVA), Kruskal-Wallis or chi-square 
tests, depending on the distribution and measurement 
scale of each variable. The results are presented in 
means and standard deviations (SD), medians and 
interquartilic ranges (IQR) or proportions.
Analysis of covariance (ANCOVA) was used for 
evaluating differences by intervention group in the 
secondary outcomes, using the last measurement (16th 
week) as dependent variable and adjusting for the 
baseline measurement. Prior to ANCOVA, the Shapiro-
Wilk test was performed to determine the normality 
of the data. When the asumption of normality was not 
fullfilled, a robust regression analysis was applied.
The comparisons for the protective sensation 
abnormality and the dimensions of quality of life, 
between the baseline and the last measurement (16th 
week) for each intervention group, were evaluated 
using a McNemar χ2 test and the sign test respectively.
Healing at the 16th week, between the three intervention 
groups, was evaluated using a Fisher´s exact test. 
STATA  version 9,0 software was used for the analysis 
and P≤ 0,05 was considered significant.
RESULTS
The CONSORT statement’s instructions and lists of 
controls were followed in this randomized clinical 
trial. A total of 98 individuals were evaluated for 
participation in the study; 65 subjects did not meet the 
inclusion criteria and five individuals pulled out the 
study for reasons unrelated to the treatment. Intention 
to treat analysis was applied to one participant. Finally 
twenty-eight patients complied with the study protocol 
LLLT (n=9), HVPC (n=10) and CG (n=9), (Figure 1), 
mean age 59,3 ± 11,8 years, mean duration of diabetes 
11,2 ± 10,1 years and 42,9% male. Ulcers duration 
16,2 ± 34,6 months and a total of 42 ulcers distributed 
by intervention group 14, 15 and 13 ulcers for LLLT, 
HVPC and CG respectively.
Figure 1. CONSORT flow diagram.
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Clinical baseline characteristics
There were no significant differences between 
intervention groups regarding baseline variables or 
wound characteristics (Table 1). Protective sensation 
in plantar nerve distribution was altered in 75%  of the 
subjects (21/28) and 71% of them (20/28) for the sural 
nerve. The following records of NCS were absent: 1 
for posterior tibial, 8 for sural nerve and 13 for plantar 
nerve; the NCV values were abnormal for the same 
nerves in 19, 6 and 4 subjects, respectively (Table 2). 
Table 1. Characteristics of the wounds at the baseline.
Variable 
Intervention Group
LLLT 
(n:9)
HVPC 
(n:10) CG (n:9)
Number of ulcers 
per patient
1
2
3
4
6
1
2
0
7
2
0
1
7
0
2
0
Classification 
(Wagner)
Grade 1 (N° 
ulcers)
Grade 2 (N° 
ulcers)
14
0
13
2
11
2
Median ulcers 
duration 
(month)*
4,1
[1,2 – 
4,7]
2,9
[1,2 – 12,1]
12,2
[8,4 – 18,1]
Location
Plantar region:
 Anterior
Media
Posterior
Medial region:
Posterior
Anterior
Lateral region:
Anterior
Posterior
Dorsal region:
Anterior
Posterior
Anterior leg 
4
2
0
5
0
0
1
0
1
2
3
2
1
2
0
0
0
3
4
0
4
5
2
0
0
1
1
1
1
1
Total Area (cm2)* 62,9[23,1 – 
172,2]
20
[11,7 – 
131,0]
41,6
[17,5 – 
398,3]
Depth (cm)*
0,4
[0,1 – 
0,4]
0,3
[0,1 – 0,5]
0,4
[0 – 0,7]
*Median [IQR], LLLT (Low level laser therapy); HVPC (High 
voltage pulsed current); CG (control group),
Table 2. Protective sensation and nerve conduction 
abnormalities by intervention group at the baseline.
Variable
Intervention Group
LLLT 
(n:9)
HVPC 
(n:10)
CG
(n:9)
Protective 
Sensation  
Abnormality*
(≤ 6 positive 
responsers)
Sural Region 7 6 7
Plantar 
Region
8 5 8
Sural NCS
Absent 
Potential 1 3 4
Abnormal 
NCV 2 2 2
NCV m/s… 31,8 (16,9)
26,2  
(21,9)
16,4  
(20,8)
Amplitude 
(uV)…
4,2  
(4,8)
3,1  
(4,1)
5,8  
(8,9)
Medial Plantar 
NCS
Absent 
Potential 4 4 5
Abnormal 
NCV 1 2 1
NCV (m/s)… 12,3 (15,8)
15,7  
(14,3)
8,4  
(16,6)
Amplitude 
(uV)…
0,47 
(0,6)
0,45  
(0,4)
0,38  
(0,7)
Posterior Tibial 
NCS (Motor)
Absent 
Potential 0 0 1
Abnormal 
NCV 7 6 6
NCV (m/s)… 35,0 (4,0)
36,7  
(6,6)
30,0  
(13,7)
Distal 
Amplitude 
(mV)†
3,8  
(3,3)
5,0  
(3,2)
2,6 
(3,6)
* Abnormal NCV: sural nerve <34,68m/s, posterior tibial 
<40,63m/s and plantar nerve <24,4m/s, 
… Mean (SD), LLLT (Low level laser therapy); HVPC (High 
voltage pulsed current); CG (control group),
EuroQOL-5D baseline results showed a moderate level 
of overall health status self perception on a EQ VAS 
(0-100 scale), mean 67,8+18,6 for LLLT, 79,9+27,1 for 
HVPC and for CG 61,1+28,9. None of the individuals 
registered extreme problems, and all subjects reported 
to have “some problems” health-related for some of 
dimensions assessed.
Primary outcomes
Healing was achieved by 7/9 (77,7%), 8/10 (80%) and 
6/9 (66%) participants with LLLT, HVPC and CG, 
respectively, during the 16 weeks of intervention.We 
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did not find significant differences between the three 
intervention groups (p=0,87).
Two patients (1/LLLT and 1/HVPC) could not be 
evaluated at the end of the 60 days because they did not 
attend the last evaluation. The extent of 30 and 60 days 
was maintained indicating that no wounds underwent 
regression.
Secondary outcomes
The healing proportion in weeks 4, 8, 12 and 16 
increased in all groups, most subjects (21/28) reaching 
75% or more closure during the 16 weeks, however the 
HVPC group showed higher dispersion of data at 4th 
and 8th weeks (Figure 2). LLLT and HPVC were closer 
to 100% of healing with less dispersion at 16th week . 
Figure 2. Ulcer healing proportion at 4, 8, 12 and 16 weeks by intervention 
group, CG: control group; HVPC: high voltage pulse current group; LL LT: 
low level laser therapy group, Healing Proportion: calculated taking account 
the total area, from the sum of all ulcers by patient.
No significant differences between intervention groups 
for the healing proportion at 16th week  (LLLT p=0,40, 
HVPC p=0,36), compared to CG were found; data was 
adjusted for healing proportion at the 4th week.
There were no significant differences found for 
the abnormal protective sensation between the two 
intervention groups for either of the nerves tested 
(p>0,52). 
No significant differences were found for the NCS 
parameters studies between the intervention groups 
(p>0,11) for either tibial motor, plantar or sural nerves.
The quality of life with EQ VAS did not demonstrate 
significant differences between the three intervention 
groups (ANCOVA p>0,18, Figure 3).  Only when the 
sign test analysis was done, a significant difference was 
detected between mobility at the baseline and after the 
6th week of intervention for the LLLT group (p=0,016). 
DISCUSSION
The pathophysiology of DM is likely to cause a delay in 
the healing process and therefore increases the wound 
closure time,  worseing the quality of the healed tissue. 
Some factors that contribute to delaying diabetic 
foot ulcer healing are inhibition of the inflammatory 
response, angiogenesis, fibroplasia and alterations 
in extracellular matrix differentiation and collagen 
deposition 24. Also poor nutritional support for cells, 
senescent fibroblasts being produced and decreased 
proliferative response to growth factors. Experimental 
studies in animal diabetic models, have reported that 
the initial healing phase has a slow beginning and 
tends to last longer, mainly due to a lower neutrophil 
density 25. Also, Schindl et al.16 reported that the ulcers 
produced by diverse causes healed faster than those 
caused by diabetes. 
114
MARÍA CRISTINA SANDOVAL ORTÍZ, ESPERANZA HERRERA VILLABONA, 
DIANA MARINA CAMARGO LEMOS, RAFAEL CASTELLANOS
To the authors knowledge, no human studies have been 
conducted that  compare LLLT and HVPC in diabetic 
ulcers treatment. Demir et. al. 26 conducted a study 
in healthy rats for comparing the effects of electrical 
stimulation and laser treatment on wound healing; 
the authors determined that laser light and electrical 
stimulation were significantly more effective when 
compared to control groups but the HVPC produced 
more beneficial effects during the inflammatory phase 
of healing compared to LLLT. The treatment parameters 
selected in this animal model differ from those selected 
for the current human study. 
HVPC efficacy has been evaluated in conservatively 
treated patients with chronic wounds as diabetic 
foot, venous leg and pressure ulcers. However the 
methodology of its application has not been determined 
to date and differences methodological difficult the 
comparing of studies 27.  In the current study, the HVPC 
parameters were selected based upon previous studies 
results 8-15 that support effectiveness of this physical 
agent on different types of ulcers. The HVPC treatment 
was delivered three times a week, during 45 min. 
Previous publications have reported positive healing 
outcomes following HVPC treatment protocols 5 to 
7 days per week 9,12,14.  Negative polarity was applied 
during the first three treatment sessions, given the 
benefits reported regarding the effect of electrotaxis 
on neutrophils9,10,13,15 during the inflammatory phase of 
healing. The cathode was subsequently applied to the 
wound to enhance macrophage motility and epithelial 
cell migration.
Franek et al. 28 examined the efficacy of high voltage 
stimulation for healing of venous leg ulcers in surgically 
and conservatively treated patients and they concluded 
that it is an efficient method of enhancing healing in 
conservative treatment of this clinical condition. Similar 
results were determined in the treatment of recalcitrant 
pressure ulcers and pressure ulcers 29,30.  Clinical studies 
10,12 have shown that HVPC improves blood flow and 
inhibits bacterial growth. Other reports and reviews have 
described electrotaxic effect stimulation on enhancing 
epithelial cells, fibroblast, neutrophil and macrophage 
motility 31. Nevertheless, the latter effect may occur 
because the HVPC signal mimics the endogenous 
electric fields existing in wound tissue. Physiologically, 
a measureable endogenous injury current has been 
shown to influence cellular and molecular action 
contributing to wound closure and healing. Such injury 
current continues to enhance wound repair until closure 
of the wound is achieved. The exogenous application 
of electrical stimuli in chronic wounds, such as diabetic 
foot ulcers, may activate healing mechanisms by 
restoring or enhancing an injury´s endogenous current31.
Since the laser light started being used in the clinical 
setting, it has been considered a potential source 
of photoenergy for stimulating wound healing 5,6. 
However, methodologic problems in laser light research 
(i.e. irradiation protocols, variations in cell culture 
models, the animals species studied and the types of 
wounds) have hampered laser studies being compared, 
some of which are contradictory 6,7,16-18,32.  Studies on 
Figure 3. Comparison of the overall helth status (EQ VAS), at the 
beginning and at the end of the treatment by intervention group, 
CG: control group; HVPC: high voltage pulse current group; LL 
LT: low level laser therapy group.
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cell cultures and animal models (mice and rats), support 
the use of laser on wounds 22,23,26,32-34.  Only a few case 
studies and any clinical trials have been conducted on 
humans, with controversial results. 
Taradaj et al. 35 studied the effectivity of LLLT in healing 
of venous leg ulcers and concluded that the application 
of this treatment does not enhance healing of venous 
ulcers in surgically and  conservatively treated patients. 
In other research 36 was assessed the efficacy of laser 
therapy at different wavelengths: 940, 808, and 658 nm 
for treating pressure ulcers.  The primary endpoint in this 
trial included both the percentage reduction of the ulcer 
surface area and the percentage of completely healed 
wounds after one month of therapy (ulcer healing rate). 
The secondary endpoint was the ulcer healing rate at 
the follow-up evaluation (3 months after the end of the 
study).  In total, 72 patients with stage II and III pressure 
ulcers received laser therapy once daily, 5 times per week 
for 1 month using a diode laser with a maximum output 
power of 50mW and continuous radiation emission. An 
average dose of 4 J/cm2 was applied.  The laser therapy 
at a wavelength of 658nm appeared to be effective at 
healing pressure ulcers.  The wavelengths of 808 and 
940 nm did not have any effect in this study. A review 
concluded that laser in humans does not improve wound 
healing in pressure, venous or post-surgery ulcers37.  The 
results of other previous studies have shown that there 
were no differences between the laser group and sham or 
control group 17,18,38.
Several hypotheses have addressed LLLT action 
mechanism on wound healing. Kawalec et al. 5, have 
proposed that photochemical stimulation of atoms or 
molecules by laser light, increases cellular function, 
macrophage migration  and cytokine secretion. In Schindl 
et.al.6, clinical trial using LLLT on diabetic patients 
demonstrated increase in the skin microcirculation 
which may have ocurred secondary to the liberation of 
substances which stimulated endothelial cell proliferation 
during angiogenesis 39, 40.
Others studies 32,33 have reported that laser light increases 
collagen synthesis and improves biomechanical and 
biochemical properties of injured tissues. Silveira et.al.22, 
demostrated that LLLT improves wound healing and 
significantly increases mitochondrial respiratory chain 
complex II and IV activity. Their study confirmed  Karu’s 
results 23, which suggested that cytochrome C oxidase 
(complex IV) might be activated by LLLT; this fact 
supports the previously described biostimulantion effect.
The NCS data confirmed a greater conduction loss in 
the sensory fibers of the medial plantar nerve. 50 % of 
the study population also exhibit altered NCV of the 
motor component of the tibial nerve; this condition 
shows an advanced  neuropathic state. The results of 
monofilament testing showed abnormal protective 
sensation in plantar and sural nerve cutaneous 
distribution.
Previous research 19,20 has presented conflicting 
results regarding LLLT effects on NCS parameters. 
Prendergast et. al. 19, applied monocromatic infrared 
photoenergy to the lower extremities of patients 
diagnosed with diabetic neuropathy. The conclusion is 
that this treatment was partially effective on restoring 
distal sensory perception. Zinman et. al. 20, assesed 
LLLT effect on sensory and motor deficits in diabetic 
polyneuropathy patients, no electrophysiological or 
sensory perception changes were found. In the same 
direction, in the current study neither one of the two 
biophysical agents affected NCS and/or protective 
sensation.We assume that the no treatment effect on 
the neuropathy condition may have been mainly due to 
evolution time of the disease (11,2+10,1 years) and the 
subjects’ age (59,3 +11,8 years), from this  two factors 
it can be concluded an advanced state of neuropathy, 
for which the interventions could not were effective. 
Regarding the EQ-5D dimensions, in spite of there was 
no difference in overall health status with EQ VAS, 
individual dimension analysis revealed that mobility 
dimension improved with LLLT treatment, no changes 
were observed for the other two groups.
The results did not show any difference between the 
three intervention groups for any of the analyzed 
variables. Our results are an important advance for the 
scientific support of biophysical agents (laser and high 
voltage current) use in the clinical setting, since a  few 
studies in humans are available. Besides, no controlled 
clinical studies comparing two biophysical agents’ 
effectiveness had been conducted. The small sample 
size limits this study for evaluating the differences 
between the two methods and may have decreased the 
likelihood of detecting differences between intervention 
groups for primary and secondary outcomes. In future 
studies we recommend a greater sample size as well 
as the inclusion of additional patient care components, 
such as weight off-loading, type of footwear, nutritional 
control and education related to DM and its care for 
both patients and their families.
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In conclusion the results of this study did not 
demonstrate additional effects of LLLT or HVPC to the 
standard wound care (SWC) on  healing of diabetic foot 
ulcers. Also no changes were identified in the protective 
sensation, NCS or the quality of life of patients.
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